在线多领域生活方式干预预防高危老年人认知能力下降:一项随机对照试验

IF 50 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Nature Medicine Pub Date : 2025-01-28 DOI:10.1038/s41591-024-03351-6
Henry Brodaty, Tiffany Chau, Megan Heffernan, Jeewani A. Ginige, Gavin Andrews, Michael Millard, Perminder S. Sachdev, Kaarin J. Anstey, Nicola T. Lautenschlager, John J. McNeil, Louisa Jorm, Nicole A. Kochan, Anthony Maeder, Heidi Welberry, Juan Carlo San Jose, Nancy E. Briggs, Gordana Popovic, Yorgi Mavros, Carolina Almendrales Rangel, Yian Noble, Sue Radd-Vagenas, Victoria M. Flood, Fiona O’Leary, Amit Lampit, Courtney C. Walton, Polly Barr, Maria Fiatarone Singh, Michael Valenzuela
{"title":"在线多领域生活方式干预预防高危老年人认知能力下降:一项随机对照试验","authors":"Henry Brodaty, Tiffany Chau, Megan Heffernan, Jeewani A. Ginige, Gavin Andrews, Michael Millard, Perminder S. Sachdev, Kaarin J. Anstey, Nicola T. Lautenschlager, John J. McNeil, Louisa Jorm, Nicole A. Kochan, Anthony Maeder, Heidi Welberry, Juan Carlo San Jose, Nancy E. Briggs, Gordana Popovic, Yorgi Mavros, Carolina Almendrales Rangel, Yian Noble, Sue Radd-Vagenas, Victoria M. Flood, Fiona O’Leary, Amit Lampit, Courtney C. Walton, Polly Barr, Maria Fiatarone Singh, Michael Valenzuela","doi":"10.1038/s41591-024-03351-6","DOIUrl":null,"url":null,"abstract":"Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55–77 years with modifiable dementia risk factors. Eligible participants (n = 6,104, 64% female) were randomized 1:1 to a personalized schedule of online coaching in two to four modules (targeting physical activity, nutrition, cognitive activity and depression or anxiety) or a control group that received module-eligible information only. At 3 years, the mean change in a global cognitive composite, the primary outcome, was met. The mean changes in z scores were 0.28 (95% confidence interval (CI): 0.25–0.32) for intervention, 0.10 (95% CI: 0.07–0.13) for control and 0.18 (95% CI: 0.13–0.23, P < 0.001) for the between-group difference. Trial-related adverse events occurred in 19 (0.60%) intervention and 1 (0.03%) control participant. Randomization of this internet-delivered lifestyle intervention tailored to individual dementia risk factors resulted in significantly better cognition in older adults over 3 years. This intervention is scalable with the potential for population-level rollout that may delay cognitive decline in the general community. Australian New Zealand ClinicalTrials.gov registration: ACTRN12618000851268. An online tailored coaching intervention, delivered over 3 years, improved global cognition, dementia risk, physical activity, nutrition and depression in older dementia-free community-dwelling individuals.","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"31 2","pages":"565-573"},"PeriodicalIF":50.0000,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial\",\"authors\":\"Henry Brodaty, Tiffany Chau, Megan Heffernan, Jeewani A. Ginige, Gavin Andrews, Michael Millard, Perminder S. Sachdev, Kaarin J. Anstey, Nicola T. Lautenschlager, John J. McNeil, Louisa Jorm, Nicole A. Kochan, Anthony Maeder, Heidi Welberry, Juan Carlo San Jose, Nancy E. Briggs, Gordana Popovic, Yorgi Mavros, Carolina Almendrales Rangel, Yian Noble, Sue Radd-Vagenas, Victoria M. Flood, Fiona O’Leary, Amit Lampit, Courtney C. Walton, Polly Barr, Maria Fiatarone Singh, Michael Valenzuela\",\"doi\":\"10.1038/s41591-024-03351-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55–77 years with modifiable dementia risk factors. Eligible participants (n = 6,104, 64% female) were randomized 1:1 to a personalized schedule of online coaching in two to four modules (targeting physical activity, nutrition, cognitive activity and depression or anxiety) or a control group that received module-eligible information only. At 3 years, the mean change in a global cognitive composite, the primary outcome, was met. The mean changes in z scores were 0.28 (95% confidence interval (CI): 0.25–0.32) for intervention, 0.10 (95% CI: 0.07–0.13) for control and 0.18 (95% CI: 0.13–0.23, P < 0.001) for the between-group difference. Trial-related adverse events occurred in 19 (0.60%) intervention and 1 (0.03%) control participant. Randomization of this internet-delivered lifestyle intervention tailored to individual dementia risk factors resulted in significantly better cognition in older adults over 3 years. This intervention is scalable with the potential for population-level rollout that may delay cognitive decline in the general community. Australian New Zealand ClinicalTrials.gov registration: ACTRN12618000851268. An online tailored coaching intervention, delivered over 3 years, improved global cognition, dementia risk, physical activity, nutrition and depression in older dementia-free community-dwelling individuals.\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":\"31 2\",\"pages\":\"565-573\"},\"PeriodicalIF\":50.0000,\"publicationDate\":\"2025-01-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41591-024-03351-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41591-024-03351-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

鉴于全球痴呆症负担和开发疾病改善治疗的挑战,需要有效、可扩展的痴呆症预防干预措施来应对可改变的风险因素。一项单盲随机对照试验评估了在线多领域生活方式干预在3年内预防认知能力下降的效果。参与者是无痴呆症的澳大利亚社区居民,年龄在55-77岁之间,具有可改变的痴呆症风险因素。符合条件的参与者(n = 6104,其中64%为女性)以1:1的比例随机分配到两到四个模块(针对身体活动、营养、认知活动和抑郁或焦虑)的个性化在线教练计划中,或者只接受模块合格信息的对照组。3年后,总体认知综合能力的平均变化达到了主要终点。干预组z评分的平均变化为0.28(95%可信区间(CI): 0.25-0.32),对照组为0.10 (95% CI: 0.07-0.13),组间差异为0.18 (95% CI: 0.13-0.23, P < 0.001)。试验相关不良事件发生在19名(0.60%)干预组和1名(0.03%)对照组。这种针对个体痴呆风险因素的互联网提供的生活方式干预的随机化,在3年内显著改善了老年人的认知能力。这种干预是可扩展的,有可能在人群水平上推广,可能会延缓一般社区的认知能力下降。澳大利亚新西兰临床试验。gov注册:ACTRN12618000851268。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
An online multidomain lifestyle intervention to prevent cognitive decline in at-risk older adults: a randomized controlled trial
Effective, scalable dementia prevention interventions are needed to address modifiable risk factors given global burden of dementia and challenges in developing disease-modifying treatments. A single-blind randomized controlled trial assessed an online multidomain lifestyle intervention to prevent cognitive decline over 3 years. Participants were dementia-free community-dwelling Australians aged 55–77 years with modifiable dementia risk factors. Eligible participants (n = 6,104, 64% female) were randomized 1:1 to a personalized schedule of online coaching in two to four modules (targeting physical activity, nutrition, cognitive activity and depression or anxiety) or a control group that received module-eligible information only. At 3 years, the mean change in a global cognitive composite, the primary outcome, was met. The mean changes in z scores were 0.28 (95% confidence interval (CI): 0.25–0.32) for intervention, 0.10 (95% CI: 0.07–0.13) for control and 0.18 (95% CI: 0.13–0.23, P < 0.001) for the between-group difference. Trial-related adverse events occurred in 19 (0.60%) intervention and 1 (0.03%) control participant. Randomization of this internet-delivered lifestyle intervention tailored to individual dementia risk factors resulted in significantly better cognition in older adults over 3 years. This intervention is scalable with the potential for population-level rollout that may delay cognitive decline in the general community. Australian New Zealand ClinicalTrials.gov registration: ACTRN12618000851268. An online tailored coaching intervention, delivered over 3 years, improved global cognition, dementia risk, physical activity, nutrition and depression in older dementia-free community-dwelling individuals.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
期刊最新文献
AI-induced never-skilling in medical education. Semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial. Naming in medicine: how disease nomenclature shapes diagnosis, research and patient lives. Resetting autoimmune disease with CAR cell therapies. Integrating public health into house design.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1